Last reviewed · How we verify
Vitamin E capsule
Vitamin E acts as a lipophilic antioxidant that neutralizes free radicals and protects cell membranes from oxidative damage.
Vitamin E acts as a lipophilic antioxidant that neutralizes free radicals and protects cell membranes from oxidative damage. Used for Vitamin E deficiency, Antioxidant supplementation for general health maintenance, Adjunctive therapy in conditions associated with oxidative stress.
At a glance
| Generic name | Vitamin E capsule |
|---|---|
| Also known as | E-Cap, Batch No. 461016, Tocopheryl Acetate, Evion capsule, placebo |
| Sponsor | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
| Drug class | Antioxidant vitamin |
| Modality | Small molecule |
| Therapeutic area | Nutritional supplementation; Cardiovascular; Neurology |
| Phase | FDA-approved |
Mechanism of action
Vitamin E (alpha-tocopherol) is a fat-soluble vitamin that donates electrons to free radicals, preventing oxidative stress and lipid peroxidation in cell membranes. It works synergistically with other antioxidant systems to maintain cellular integrity and reduce inflammation. This mechanism underlies its use in preventing or managing conditions associated with oxidative stress.
Approved indications
- Vitamin E deficiency
- Antioxidant supplementation for general health maintenance
- Adjunctive therapy in conditions associated with oxidative stress
Common side effects
- Gastrointestinal upset
- Headache
- Fatigue
- Bleeding (at very high doses)
Key clinical trials
- Vitamin E Dosing Study (PHASE2)
- The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFLD) (PHASE2)
- Vitamin E Plus Mefenamic Acid Versus Mefenamic Acid Alone for Treating Primary Dysmenorrhea in Women (PHASE4)
- A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV. (NA)
- Tocotrienol Against the Progression of End Stage Liver Disease (PHASE2)
- Fibrosis-Modulating Effects of Metformin and Pirfenidone in Oral Submucous Fibrosis (PHASE1, PHASE2)
- Efficacy and Safety of Tocotrienols in CADASIL (PHASE2)
- Alii Supplement Study (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vitamin E capsule CI brief — competitive landscape report
- Vitamin E capsule updates RSS · CI watch RSS
- Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh portfolio CI